Burkhard Haefner

1.3k total citations · 1 hit paper
14 papers, 996 citations indexed

About

Burkhard Haefner is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Burkhard Haefner has authored 14 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Burkhard Haefner's work include Protein Kinase Regulation and GTPase Signaling (4 papers), NF-κB Signaling Pathways (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Burkhard Haefner is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), NF-κB Signaling Pathways (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Burkhard Haefner collaborates with scholars based in Belgium, United Kingdom and United States. Burkhard Haefner's co-authors include J. Van Wauwe, Robert D. Gordon, Eva Mortier, Alan Richardson, Peter Verhasselt, Stefan Masure, Jan‐Jaap Wesselink, Margaret C. Frame, Valerie J. Fincham and C. Peter Downes and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Burkhard Haefner

14 papers receiving 928 citations

Hit Papers

Drugs from the deep: marine natural products as drug cand... 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Drugs from the deep: marine natural products as drug candidates
    2003 534 citations Burkhard Haefner Drug Discovery Today profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burkhard Haefner Belgium 10 497 308 259 165 127 14 996
Esther A. Guzmán United States 21 337 0.7× 352 1.1× 267 1.0× 123 0.7× 387 3.0× 41 1.0k
Seok Bean Song South Korea 20 447 0.9× 151 0.5× 113 0.4× 116 0.7× 66 0.5× 52 943
Sandra L. Kuentzel United States 16 745 1.5× 175 0.6× 240 0.9× 133 0.8× 289 2.3× 25 1.4k
Karen TenDyke United States 19 549 1.1× 233 0.8× 258 1.0× 136 0.8× 274 2.2× 49 1.2k
Junji Morimoto Japan 17 562 1.1× 114 0.4× 135 0.5× 93 0.6× 71 0.6× 55 1.0k
Qi Shen China 21 817 1.6× 101 0.3× 265 1.0× 124 0.8× 112 0.9× 60 1.5k
Tetsuya Someno Japan 17 362 0.7× 154 0.5× 258 1.0× 81 0.5× 172 1.4× 52 764
M. S. de Carvalho United States 8 324 0.7× 133 0.4× 128 0.5× 81 0.5× 84 0.7× 8 598
Lihan Zhang China 20 626 1.3× 158 0.5× 495 1.9× 46 0.3× 161 1.3× 61 1.0k
Kylie Hood New Zealand 14 315 0.6× 172 0.6× 107 0.4× 113 0.7× 164 1.3× 17 667

Countries citing papers authored by Burkhard Haefner

Since Specialization
Citations

This map shows the geographic impact of Burkhard Haefner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkhard Haefner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkhard Haefner more than expected).

Fields of papers citing papers by Burkhard Haefner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkhard Haefner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkhard Haefner. The network helps show where Burkhard Haefner may publish in the future.

Co-authorship network of co-authors of Burkhard Haefner

This figure shows the co-authorship network connecting the top 25 collaborators of Burkhard Haefner. A scholar is included among the top collaborators of Burkhard Haefner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burkhard Haefner. Burkhard Haefner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Versele, Matthias, Burkhard Haefner, Berthold Wroblowski, et al.. (2016). Abstract 4800: Covalent Flt3-Cys828 inhibition represents a novel therapeutic approach for the treatment of Flt3-ITD and Flt3-D835 mutant acute myeloid leukemia. Cancer Research. 76(14_Supplement). 4800–4800. 2 indexed citations
2.
Dalgleish, Angus & Burkhard Haefner. (2006). The link between inflammation and cancer : wounds that do not heal. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 11 indexed citations
3.
Haefner, Burkhard. (2006). Targeting NF-κB in Anticancer Adjunctive Chemotherapy. Cancer treatment and research. 130. 219–245. 14 indexed citations
4.
Haefner, Burkhard. (2005). The Transcription Factor NF-κB as Drug Target. Progress in medicinal chemistry. 43. 137–188. 7 indexed citations
5.
Haefner, Burkhard. (2003). Drugs from the deep: marine natural products as drug candidates. Drug Discovery Today. 8(12). 536–544. 534 indexed citations breakdown →
6.
Wauwe, J. Van & Burkhard Haefner. (2003). Glycogen synthase kinase-3 as drug target: From wallflower to center of attention. Drug News & Perspectives. 16(9). 557–557. 52 indexed citations
7.
Haefner, Burkhard. (2002). NF-κB: arresting a major culprit in cancer. Drug Discovery Today. 7(12). 653–663. 112 indexed citations
8.
Masure, Stefan, Burkhard Haefner, Jan‐Jaap Wesselink, et al.. (1999). Molecular cloning, expression and characterization of the human serine/threonine kinase Akt‐3. European Journal of Biochemistry. 265(1). 353–360. 131 indexed citations
9.
Weissinger, Eva M., Günther Eißner, Burkhard Haefner, et al.. (1997). Inhibition of the Raf-1 Kinase by Cyclic AMP Agonists Causes Apoptosis of v-abl-Transformed Cells. Molecular and Cellular Biology. 17(6). 3229–3241. 60 indexed citations
10.
Haefner, Burkhard, et al.. (1997). Distinctive regulation of v-Src-associated phosphatidylinositol 3-kinase during PC12 cell differentiation. Biochemical Journal. 328(2). 649–655. 3 indexed citations
11.
Haefner, Burkhard, Ruth Baxter, Valerie J. Fincham, C. Peter Downes, & Margaret C. Frame. (1995). Cooperation of Src Homology Domains in the Regulated Binding of Phosphatidylinositol 3-Kinase. Journal of Biological Chemistry. 270(14). 7937–7943. 32 indexed citations
12.
Fincham, Valerie J., et al.. (1994). Functions of the v‐SRC protein tyrosine kinase. Cell Biology International. 18(5). 337–344. 13 indexed citations
13.
Catling, Andrew D., Valerie J. Fincham, Margaret C. Frame, Burkhard Haefner, & J A Wyke. (1994). Mutations in v-Src SH3 and catalytic domains that jointly confer temperature-sensitive transformation with minimal temperature-dependent changes in cellular tyrosine phosphorylation. Journal of Virology. 68(7). 4392–4399. 9 indexed citations
14.
Shearman, M. S., C M Heyworth, T. M. Dexter, et al.. (1993). Haemopoietic stem cell development to neutrophils is associated with subcellular redistribution and differential expression of protein kinase C subspecies. Journal of Cell Science. 104(1). 173–180. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther A. Guzmán Breakdown of academic impact, for papers by Seok Bean Song Breakdown of academic impact, for papers by Sandra L. Kuentzel Breakdown of academic impact, for papers by Karen TenDyke Breakdown of academic impact, for papers by Junji Morimoto Breakdown of academic impact, for papers by Qi Shen Breakdown of academic impact, for papers by Tetsuya Someno Breakdown of academic impact, for papers by M. S. de Carvalho Breakdown of academic impact, for papers by Lihan Zhang Breakdown of academic impact, for papers by Kylie Hood
Rankless by CCL
2026